MaaT Pharma S.A.
MAAT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €15 | €20 | €31 | €24 |
| Short-Term Investments | €0 | €0 | €0 | €0 |
| Receivables | €18 | €2 | €7 | €5 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €2 | €6 | €2 | €2 |
| Total Curr. Assets | €36 | €28 | €41 | €32 |
| Property Plant & Equip (Net) | €8 | €9 | €9 | €9 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €3 | €2 | €1 | €1 |
| Long-Term Investments | €1 | €0 | €0 | €0 |
| Tax Assets | €0 | €0 | €0 | -€1 |
| Other NC Assets | €2 | €0 | €0 | €2 |
| Total NC Assets | €13 | €11 | €10 | €11 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €49 | €39 | €51 | €43 |
| Liabilities | – | – | – | – |
| Payables | €10 | €9 | €6 | €6 |
| Short-Term Debt | €3 | €3 | €7 | €3 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €0 | €0 | €0 | €0 |
| Other Curr. Liab. | €3 | €3 | €2 | €2 |
| Total Curr. Liab. | €16 | €15 | €15 | €12 |
| LT Debt | €12 | €13 | €10 | €11 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €13 | €1 | €1 | €0 |
| Total NC Liab. | €25 | €14 | €11 | €11 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €6 | €6 | €5 | €5 |
| Total Liabilities | €41 | €28 | €25 | €22 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €2 | €1 | €1 | €1 |
| Retained Earnings | -€13 | -€26 | -€11 | -€18 |
| AOCI | €0 | €0 | -€0 | €0 |
| Other Equity | €20 | €35 | €35 | €37 |
| Total Equity | €8 | €10 | €26 | €20 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €49 | €39 | €51 | €43 |
| Net Debt | -€1 | -€4 | -€14 | -€10 |